PWM
ABBV icon

Prentice Wealth Management’s AbbVie ABBV Stock Holding History

Prentice Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
6,526
-68
-1% -$14.6K 0.34% 42
2026
Q1 		$1.43M Buy
6,594
+6
+0.1% +$1.33K 0.32% 42
2025
Q4 		$1.51M Buy
6,588
+180
+3% +$41K 0.34% 40
2025
Q3 		$1.48M Buy
6,408
+279
+5% +$56.8K 0.37% 37
2025
Q2 		$1.14M Sell
6,129
-110
-2% -$20.4K 0.3% 42
2025
Q1 		$1.31M Sell
6,239
-28
-0.4% -$5.44K 0.38% 38
2024
Q4 		$1.11M Buy
6,267
+190
+3% +$34.9K 0.32% 40
2024
Q3 		$1.2M Sell
6,077
-15
-0.2% -$2.8K 0.36% 37
2024
Q2 		$1.04M Buy
6,092
+28
+0.5% +$4.64K 0.34% 41
2024
Q1 		$1.1M Buy
6,064
+212
+4% +$36.5K 0.38% 37
2023
Q4 		$907K Buy
5,852
+339
+6% +$49.4K 0.35% 35
2023
Q3 		$822K Buy
5,513
+30
+0.5% +$4.4K 0.37% 35
2023
Q2 		$739K Buy
5,483
+658
+14% +$96.5K 0.34% 36
2023
Q1 		$769K Buy
4,825
+36
+0.8% +$5.5K 0.37% 35
2022
Q4 		$774K Buy
4,789
+122
+3% +$18.7K 0.39% 29
2022
Q3 		$629K Buy
4,667
+267
+6% +$38.3K 0.34% 28
2022
Q2 		$674K Buy
4,400
+80
+2% +$12.2K 0.69% 19
2022
Q1 		$702K Buy
4,320
+125
+3% +$18.2K 0.34% 30
2021
Q4 		$572K Sell
4,195
-88
-2% -$10.4K 0.27% 39
2021
Q3 		$462K Buy
4,283
+45
+1% +$5.14K 0.22% 49
2021
Q2 		$477K Buy
4,238
+798
+23% +$89.9K 0.24% 43
2021
Q1 		$372K Buy
+3,440
New +$368K 0.21% 49

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Prentice Wealth Management's ABBV Position: Q2 2026 in Review

Prentice Wealth Management reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $14.6K and leaving 6,526 shares worth $1.64M. The position accounts for 0.34% of the portfolio, ranked #42.

Prentice Wealth Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Prentice Wealth Management held 6,526 shares of AbbVie worth $1.64M as of Q2 2026.
  • Prentice Wealth Management sold 68 AbbVie shares in Q2 2026, an estimated $14.6K.
  • AbbVie made up 0.34% of Prentice Wealth Management's portfolio in Q2 2026, its #42 holding.
  • Prentice Wealth Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prentice Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.